The Latest Breaking News from PTSD

Ah, picture day at school! For some, it evokes a huge wave of nostalgia. For others—a dash of PTSD if your photos never came out the way you wanted them to. The post It’s Picture Day: 56 Parents That Took To X To Share Just How Wrong Things Can Go…

Dog attack-related injuries have skyrocketed in the past decade.

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder. It is the first such decision issued on a psychedelic drug application.

The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical trial, which would take years and millions of dollars.

The Food and Drug Administration declined to approve MDMA as the first psychedelic drug used to treat post-traumatic stress disorder.

FDA declines approval for MDMA as PTSD treatment, citing safety and efficacy concerns. Further trials needed.

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD

To move the drugs forward, manufacturers may need to follow the agency’s advice for elevating evidence quality

Kansas City #Chiefs running back Clyde Edwards-Helaire revealed his ongoing battle with PTSD during a press conference on Thursday. | @EdEastonJr